UR-144
CAS No. 1199943-44-6
UR-144( UR 144 | UR144 )
Catalog No. M10716 CAS No. 1199943-44-6
A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameUR-144
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.
-
DescriptionA potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM, >80-fold selectivity over CB2 (Ki=150 nM); possesses an EC50 of 421 nM for human CB1 receptors, and 72 nM for human CB2 receptors, produces bradycardia and hypothermia in rats at a dose of 10 mg/kg.
-
In Vitro——
-
In Vivo——
-
SynonymsUR 144 | UR144
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1199943-44-6
-
Formula Weight311.461
-
Molecular FormulaC21H29NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCn1cc(c2c1cccc2)C(=O)C3C(C3(C)C)(C)C
-
Chemical Name(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Banister SD, et al. ACS Chem Neurosci. 2015 Aug 19;6(8):1445-58.
2. Dhopeshwarkar A, et al. J Pharmacol Exp Ther. 2016 Aug;358(2):342-51.
molnova catalog
related products
-
Otenabant
A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively; has low affinity (Ki=7600 nM) for human CB2 receptors; reverses cannabinoid agonist mediated responses, reduces food intake, and increases energy expenditure and fat oxidation in rodents.ObesityPhase 3 Discontinued
-
JTE907
A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.
-
NESS-0327
A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.